EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 157 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $123 | -10.2% | 4,350 | -7.5% | 0.00% | – |
Q4 2022 | $137 | -99.9% | 4,703 | +8.6% | 0.00% | – |
Q3 2022 | $114,000 | -40.6% | 4,330 | 0.0% | 0.00% | – |
Q2 2022 | $192,000 | +62.7% | 4,330 | +80.1% | 0.00% | – |
Q1 2022 | $118,000 | -3.3% | 2,404 | -0.0% | 0.00% | – |
Q4 2021 | $122,000 | +1.7% | 2,405 | +11.5% | 0.00% | – |
Q3 2021 | $120,000 | +62.2% | 2,157 | +34.0% | 0.00% | – |
Q4 2020 | $74,000 | +1380.0% | 1,610 | +1208.9% | 0.00% | – |
Q3 2020 | $5,000 | -91.8% | 123 | -90.4% | 0.00% | – |
Q2 2020 | $61,000 | -99.7% | 1,277 | -99.6% | 0.00% | -100.0% |
Q2 2018 | $24,388,000 | +42.7% | 322,340 | -0.6% | 0.04% | +44.8% |
Q1 2018 | $17,085,000 | -13.0% | 324,257 | -11.8% | 0.03% | -14.7% |
Q4 2017 | $19,631,000 | -6.4% | 367,497 | +4.5% | 0.03% | -10.5% |
Q3 2017 | $20,973,000 | -4.5% | 351,673 | +26.4% | 0.04% | -7.3% |
Q2 2017 | $21,953,000 | +990.6% | 278,282 | +1046.4% | 0.04% | +925.0% |
Q1 2017 | $2,013,000 | -24.0% | 24,275 | -27.3% | 0.00% | -20.0% |
Q4 2016 | $2,649,000 | +13.3% | 33,400 | 0.0% | 0.01% | 0.0% |
Q3 2016 | $2,338,000 | +80.5% | 33,400 | 0.0% | 0.01% | +66.7% |
Q2 2016 | $1,295,000 | – | 33,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |